{
    "clinical_study": {
        "@rank": "141375", 
        "arm_group": [
            {
                "arm_group_label": "TRI102-ADD-001", 
                "arm_group_type": "Experimental", 
                "description": "Active"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether TRI102-ADD-001 is effective in the\n      treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children ages 6-12."
        }, 
        "brief_title": "TRI102-ADD-001 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Attention Deficit Disorder With Hyperactivity", 
        "condition_browse": {
            "mesh_term": [
                "Attention Deficit Disorder with Hyperactivity", 
                "Hyperkinesis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Children aged 6 to 12 years with ADHD who require pharmacologic treatment for this\n             condition\n\n        Exclusion Criteria:\n\n          -  Other serious illnesses or conditions that would put the patient at particular risk\n             for safety events or would interfere with treatment/assessment of ADHD"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "12 Years", 
            "minimum_age": "6 Years"
        }, 
        "enrollment": {
            "#text": "90", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02083783", 
            "org_study_id": "TRI102-ADD-001"
        }, 
        "intervention": [
            {
                "arm_group_label": "TRI102-ADD-001", 
                "description": "Active", 
                "intervention_name": "TRI102-ADD-001", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "March 10, 2014", 
        "location": [
            {
                "contact": {
                    "email": "wigalsb@gmail.com", 
                    "last_name": "Sharon Wigal, PhD", 
                    "phone": "949-978-9715"
                }, 
                "facility": {
                    "address": {
                        "city": "Newport Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92660"
                    }, 
                    "name": "Newport Beach Clinical Research Associates, Inc."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "drann87@aol.com", 
                    "last_name": "Ann Childress, MD", 
                    "phone": "702-838-0742"
                }, 
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89128"
                    }, 
                    "name": "Center for Psychiatry and Behavioral Medicine, Inc."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "scott.kollins@dm.duke.edu", 
                    "last_name": "Scott Kollin, PhD", 
                    "phone": "919-681-0014"
                }, 
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27705"
                    }, 
                    "name": "Duke University Medical Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "drmattbrams@aol.com", 
                    "last_name": "Matthew Brams, MD", 
                    "phone": "832-251-7000"
                }, 
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77007"
                    }, 
                    "name": "Bayou City Research"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jmturnbow@hotmail.com", 
                    "last_name": "John Turnbow, MD", 
                    "phone": "806-241-5178"
                }, 
                "facility": {
                    "address": {
                        "city": "Lubbock", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "79423"
                    }, 
                    "name": "Westex Clinical Investigation"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "TRI102-ADD-001 in the Treatment of Children With ADHD: A Laboratory Classroom Study", 
        "overall_official": {
            "affiliation": "Newport Beach Clinical Research Associates, Inc.", 
            "last_name": "Sharon Wigal, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "SKAMP (Swanson, Kotkin, Agler, M-Flynn, and Pelham Scale)", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02083783"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "PERMP (Permanent Product Measure of Performance)", 
            "safety_issue": "No", 
            "time_frame": "1 day"
        }, 
        "source": "Tris Pharma, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tris Pharma, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}